The government has fixed ceiling prices of 849 formulations, including two coronary stents, till November 2017, Parliament was informed today.
The government has fixed the ceiling prices of 849 formulations, including two coronary stents, under revised Schedule I, based on National List of Essential Medicines, 2015," Minister of State for Chemicals & Fertilisers Mansukh L Mandaviya said in a written reply in Rajya Sabha.
The National Pharmaceuticals Pricing Authority (NPPA) fixes the ceiling prices of medicines listed in the Drugs (Prices Control) Order, 2013 (DPCO 2013), he added.
Out of the 849 formulations, the ceiling prices of 59 formulations were reduced by above 40 per cent with respect to maximum price, Mandaviya said.
In case of 24 formulations, the slab wise percentage reduction with respect to maximum price was between 35-40 per cent, he added.
The prices of 233 formulations were reduced by up to five per cent, Mandaviya said.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.